Our research using observational cohort studies and randomized controlled trials has been vital to answering many important questions and optimizing clinical practices to improve maternal and child health. The OMNI Research Group is recognized for its expertise and success in running single and multi-site birth cohorts.
Studies that are actively seeking new participants are highlighted below. Individuals receiving care at The Ottawa Hospital, have the opportunity to identify themselves as being interested in participating in research. If you are receiving care at The Ottawa Hospital and have provided permission to be contacted for research purposes, you may be approached to discuss other research opportunities involving data or sample collection.
The purpose of this study is to find out what effects COVID-19 vaccines have on the immune systems of pregnant women/individuals and their babies.
The purpose of this study is to help inform the feasibility of a larger future research study involving pregnant women/individuals using/consuming cannabis during pregnancy and the postpartum period.
The purpose of this study is to gain insight from patients and health care providers to assess their opinions in participating or supporting a clinical trial to evaluate induction of labour at 38-weeks’ gestation compared to current expectant management in those pregnancies with Gestational Diabetes Mellitus (GDM).
The goal of this study is to see if there are differences in the placenta’s ability to transfer nutrients in pregnant women who exercise regularly compared to women who do not exercise regularly.
IMPACT is a study being carried out across Ontario, focused on understanding how the placenta develops and functions during pregnancy. The study is also interested in understanding how different prescribed and recreational drugs used during pregnancy can impact the placenta and growth of the baby.
Some women are at risk for developing blood clots in the legs or lungs (thrombosis) after they deliver a baby (postpartum). You may be eligible to participate in the PARTUM trial if you are pregnant or are postpartum and have risk factors for blood clots.
